These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11529922)

  • 1. Anti-cytokeratin antibodies in sera of the patients with autoimmune hepatitis.
    Murota M; Nishioka M; Fujita J; Dobashi N; Wu F; Ohtsuki Y; Hojo S; Takahara J; Kuriyama S
    Clin Exp Immunol; 2001 Aug; 125(2):291-9. PubMed ID: 11529922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis.
    Dobashi N; Fujita J; Murota M; Ohtsuki Y; Yamadori I; Yoshinouchi T; Ueda R; Bandoh S; Kamei T; Nishioka M; Ishida T; Takahara J
    Lung; 2000; 178(3):171-9. PubMed ID: 10871435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis.
    Dobashi N; Fujita J; Ohtsuki Y; Yamadori I; Yoshinouchi T; Kamei T; Tokuda M; Hojo S; Bandou S; Ueda Y; Takahara J
    Respiration; 2000; 67(4):397-401. PubMed ID: 10940793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 8 and 18 expression in imprint smears of chronic viral hepatitis, autoimmune hepatitis and hepatocellular carcinoma. A preliminary study.
    Athanassiadou P; Psyhoyiou H; Grapsa D; Gonidi M; Ketikoglou I; Patsouris E
    Acta Cytol; 2007; 51(1):61-5. PubMed ID: 17328497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Circulating Autoantibodies Levels of IgG, IgA, IgM Against Cytokeratin 18 and Cytokeratin 19 in Chronic Obstructive Pulmonary Disease.
    Xiong Y; Gao S; Luo G; Cheng G; Huang W; Jiang R; Wang Y; Cui T
    Arch Med Res; 2017 Jan; 48(1):79-87. PubMed ID: 28577873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.
    Kimura M; Tatsumi KI; Tada H; Izumi Y; Kaneko A; Kato M; Masuzawa M; Ikemoto M; Yabusaki Y; Hidaka Y; Amino N
    Clin Chim Acta; 2002 Feb; 316(1-2):155-64. PubMed ID: 11750286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin autoantibodies: useful serologic markers for toluene diisocyanate-induced asthma.
    Ye YM; Nahm DH; Kim CW; Kim HR; Hong CS; Park CS; Suh CH; Park HS
    Yonsei Med J; 2006 Dec; 47(6):773-81. PubMed ID: 17191304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis.
    Calich AL; Viana VS; Cancado E; Tustumi F; Terrabuio DR; Leon EP; Silva CA; Borba EF; Bonfa E
    Liver Int; 2013 Jul; 33(6):909-13. PubMed ID: 23522300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
    Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
    Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis.
    O'Brien C; Joshi S; Feld JJ; Guindi M; Dienes HP; Heathcote EJ
    Hepatology; 2008 Aug; 48(2):550-6. PubMed ID: 18666262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I.
    Li L; Chen M; Huang DY; Nishioka M
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1176-82. PubMed ID: 11106099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis.
    Matsumoto K; Miyake Y; Matsushita H; Ohnishi A; Ikeda F; Shiraha H; Takaki A; Nouso K; Yamamoto K
    J Gastroenterol Hepatol; 2014 Jan; 29(1):110-5. PubMed ID: 23869988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis.
    Granito A; Muratori L; Muratori P; Pappas G; Guidi M; Cassani F; Volta U; Ferri A; Lenzi M; Bianchi FB
    J Clin Pathol; 2006 Mar; 59(3):280-4. PubMed ID: 16505279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin expression in normal human thymus at different ages.
    Masunaga A; Sugawara I; Nakamura H; Yoshitake T; Itoyama S
    Pathol Int; 1997 Dec; 47(12):842-7. PubMed ID: 9503465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
    Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
    Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1.
    Zachou K; Oikonomou K; Renaudineau Y; Chauveau A; Gatselis N; Youinou P; Dalekos GN
    Aliment Pharmacol Ther; 2012 Jan; 35(1):116-25. PubMed ID: 22050113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.